October industry round-up: NICE forms alliances to enhance clinical guidance with RWE

3 Nov 2021

Written by The Evidence Base

Industry Updates Methodology Real-world evidence Stakeholder engagement

Aetion (NY, USA) has partnered with NICE (London, UK), Merck (Darmstadt, Germany) maximizes real-world data (RWD) with Syapse (CA, USA), Medidata (NY, USA) announce the launch of Medidata Link, Syneos Health acquire RxDataScience (both NC, USA), Lightship (CA, USA) invest USD$40 million to improve patient access to trials, Genesis Research (NJ, USA) improve their EVID AI service, and Clinerion (Basel, Switzerland) have expanded their services into Colombia. In this latest instalment of our regular monthly column, we summarize a selection of key real-world evidence (RWE)-focused industry developments that have taken place over the past month. The news highlights: Aetion collaborate with NICE to use real-world evidence for clinical guidance Merck employ real-world data from Syapse for oncology patients Medidata...